New immunotherapy for lung cancer shows promise of success – Science Daily
Genetic Engineering & Biotechnology News |
New immunotherapy for lung cancer shows promise of success
Science Daily Patients with metastatic non-small cell lung cancer will always progress after chemotherapy, so most patients go on to be treated with immunotherapy, a type of therapy that uses the body’s immune system to fight cancer. One class of immunotherapeutic … Immunotherapy Combo for Metastatic Lung Cancer Shows SuccessGenetic Engineering & Biotechnology News |
Genetic Engineering & Biotechnology News |
Immunotherapy Combo for Metastatic Lung Cancer Shows Success
Genetic Engineering & Biotechnology News We’ve come to the point in modern medicine where a single compound to treat a complex disease like cancer has become increasingly less of an option. However, on the positive side, the number of successful combination therapies continues to grow. For … |
|
Mechanism vital to keeping blood stem cells functional uncovered
Phys.Org The team’s key discovery was that stem cells lacking an enzyme responsible for pseudouridine modification of RNA, known as PUS7, produce abnormal amounts of protein. This protein overload leads to unbalanced stem cell growth and dramatically blocks … |
MIT Technology Review |
This company can encode your favorite song in DNA—for $100000
MIT Technology Review Leproust is cofounder and CEO of Twist Bioscience, a five-year-old startup that is, by some estimates, the world’s largest supplier of manufactured DNA strands, or synthetic genes. Custom-ordered genes are the raw material of synthetic biology and the … |
MIT Technology Review |
This company can encode your favorite song in DNA—for $100000
MIT Technology Review Leproust is cofounder and CEO of Twist Bioscience, a five-year-old startup that is, by some estimates, the world’s largest supplier of manufactured DNA strands, or synthetic genes. Custom-ordered genes are the raw material of synthetic biology and the … |